1. Academic Validation
  2. Characterization of the metabolite of AdipoRon in rat and human liver microsomes by ultra-high-performance liquid chromatography combined with Q-Exactive Orbitrap tandem mass spectrometry

Characterization of the metabolite of AdipoRon in rat and human liver microsomes by ultra-high-performance liquid chromatography combined with Q-Exactive Orbitrap tandem mass spectrometry

  • Biomed Chromatogr. 2019 Nov;33(11):e4645. doi: 10.1002/bmc.4645.
Yingying Ge 1 Yongsheng Yu 2 Yongjie Zhang 3 Xiaonan Li 3 Qingwang Liu 4
Affiliations

Affiliations

  • 1 Department of Pharmacy, Xinyang Central Hospital, Xinyang, Henan, China.
  • 2 College of Chemistry and Chemical Engineering, Xinyang Normal University, Xinyang, Henan, China.
  • 3 Clinical Pharmacokinetics Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, China.
  • 4 Precision Targeted Therapy Discovery Center, Institute of Technology Innovation, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, China.
Abstract

AdipoRon is an orally active Adiponectin Receptor Agonist. The aim of this study was to characterize the metabolites of AdipoRon in rat and human liver microsomes using ultra-high performance liquid chromatography combined with Q-Exactive Orbitrap tandem mass spectrometry (UPLC-Q-Exactive-Orbitrap-MS) together with data processing techniques including extracted ion chromatograms and a mass defect filter. AdipoRon (10 μm) was incubated with liver microsomes in the presence of NADPH and this resulted in a total of 11 metabolites being detected. The identities of these metabolites were characterized by comparing their accurate masses and fragment ions as well as their retention times with those of AdipoRon using MetWorks software. Metabolites M1-M3, M6, and M8-M11 were identified for the first time. Metabolite M4, the major metabolite both in rat and human liver microsomes, was further confirmed using the reference standard. Our results revealed that the metabolic pathways of AdipoRon in liver microsomes were N-dealkylation (M2), hydroxylation (M, M5-M9), carbonyl reduction (M4) and the formation of amide (M10 and M11). Our results provide valuable information about the in vitro metabolism of AdipoRon, which would be helpful for us to understand the mechanism of the elimination of AdipoRon and, in turn, its effectiveness and toxicity.

Keywords

AdipoRon; LC-MS; liver microsomes; metabolic pathways; metabolite characterization.

Figures
Products